Launer BM, McVary KT, Ricke WA, Lloyd GL. The rising worldwide impact of benign prostatic hyperplasia. BJU Int. 2021;127:722–8.

Article  Google Scholar 

Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, et al. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). Edn. presented at the EAU Annual Congress Amsterdam. Arnhem, The Netherlands: EAU Guidelines Office; 2020. http://uroweb.org/guidelines/compilations-of-all-guidelines/ ISBN 978-94-92671-07-3

Google Scholar 

Cindolo L, Pirozzi L, Fanizza C, Romero M, Tubaro A, Autorino R, et al. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol. 2015;68:418–25. https://doi.org/10.1016/j.eururo.2014.11.006

Article  PubMed  Google Scholar 

Gu C, Zhou N, Gurung P, Kou Y, Luo Y, Wang Y, et al. Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies. World J Urol. 2020;38:907–18.

Article  Google Scholar 

Manfredi C, Arcaniolo D, Spatafora P, Crocerossa F, Fusco F, Verze P, et al. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. Minerva Urol Nephrol. 2021. https://doi.org/10.23736/S2724-6051.21.04530-4. Epub ahead of print

Checcucci E, Veccia A, De Cillis S, Piramide F, Volpi G, Amparore D, et al. New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes. Eur Urol Open Sci. 2021;33:28–41. https://doi.org/10.1016/j.euros.2021.08.009

Article  PubMed  PubMed Central  Google Scholar 

McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin R, et al. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2021;206:715–24.

Article  Google Scholar 

Siena G, Cindolo L, Ferrari G, Maruzzi D, Fasolis G, Condorelli SV, et al. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study. World J Urol. 2021;39:3875–80. https://doi.org/10.1007/s00345-021-03642-4

CAS  Article  PubMed  PubMed Central  Google Scholar 

Franco G, De Nunzio C, Federico G, Laurenti C. Evaluation of sexual activity after prostatic surgery for benign prostatic hyperplasia assessed by pre-operative and post-operative questionnaire. Minerva Urol Nefrol. 2005;57:331–4.

CAS  PubMed  Google Scholar 

Zheng J, Pan J, Qin Y, Huang J, Luo Y, Gao X, et al. Role for intravesical prostatic protrusion in lower urinary tract symptom: a fluid structural interaction analysis study. BMC Urol. 2015;15:86 https://doi.org/10.1186/s12894-015-0081-y

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cindolo L, Campobasso D, Ferrari G, Cicione A, De Nunzio C. Expanding indications for Rezum procedure. Urol Video J. 2022;14:100154.

Article  Google Scholar 

Cindolo L, Ferrari R, Rabito S, Siena G, Spatafora P, Ferrari G. Rezum procedure with Exime® stent: a step forward to micro-invasiveness. Minerva Urol Nephrol. 2021;73:273–5.

Article  Google Scholar 

Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F. The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol. 2011;29:205–10.

Article  Google Scholar 

Javle P, Jenkins SA, Machin DG, Parsons KF. Grading of benign prostatic obstruction can predict the outcome of Transurethral Prostatectomy. J Urol. 1998;160:1713–17.

CAS  Article  Google Scholar 

McVary KT, El-Arabi A, Roehrborn C. Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia. Sex Med. 2021;9:100454.

Article  Google Scholar 

Cocci A, Bocchino A, Cito G, De Lisa A, Russo G, Lo Giudice A, et al. Role of Rezum in the treatment of benign prostate hyperplasia: A review of the literature. Turk J Urol. 2021;47:452–60. https://doi.org/10.5152/tud.2021.21128

Article  PubMed  Google Scholar 

Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA, et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezum system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol. 2017;9:159–68.

PubMed  PubMed Central  Google Scholar 

Mollengarden D, Goldberg K, Wong D, Roehrborn C. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis. 2018;21:379–85.

Article  Google Scholar 

McVary KT, Rogers T, Roehrborn CG. Rezum Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. Urology 2019;126:171–9.

Article  Google Scholar 

Johnston MJ, Noureldin M, Abdelmotagly Y, Paramore L, Gehring T, Nedas TG, et al. Rezum water vapour therapy: promising early outcomes from the first UK series. BJU Int. 2020;126:557–8.

Article  Google Scholar 

Bole R, Gopalakrishna A, Kuang R, Alamiri J, Yang DY, Helo S, et al. Comparative postoperative outcomes of rezum prostate ablation in patients with large versus small glands. J Endourol. 2020;34:778–81.

Article  Google Scholar 

Garden EB, Shukla D, Ravivarapu KT, Kaplan SA, Reddy AK, Small AC, et al. Rezum therapy for patients with large prostates (≥80 g): initial clinical experience and postoperative outcomes. World J Urol. 2021;39:3041–8.

CAS  Article  Google Scholar 

Ines M, Babar M, Singh S, Iqbal N, Ciatto M. Real-world evidence with The Rezūm System: a retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes. Prostate 2021;81:956–70.

CAS  Article  Google Scholar 

Eredics K, Wehrberger C, Henning A, Sevcenco S, Marszalek M, Rauchenwald M et al. Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency. Prostate Cancer Prostatic Dis. 2021. https://doi.org/10.1038/s41391-021-00462-w. Online ahead of print.

Fernández-Guzmán E, Asensio Matas A, Capape Poves V, Rioja Zuazu J, Garrido Abad P, Martínez-Salamanca JI, et al. Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezūm® steam system. Actas Urol Esp. 2022;46:310–6.

Article  Google Scholar 

Whiting D, Noureldin M, Abdelmotagly Y, Johnston MJ, Brittain J, Rajkumar G, et al. Real-world Early Outcomes and Retreatment Rates Following Water Vapour Ablative Therapy for Symptomatic Benign Prostatic Hyperplasia. Eur Urol Open Sci. 2022;39:72–8.

Article  Google Scholar 

Elterman D, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC. Large, Multi-Center, Prospective Registry of Rezūm Water Vapor Therapy for Benign Prostatic Hyperplasia. Urology. 2022:S0090–4295(22)00142-X. https://doi.org/10.1016/j.urology.2022.02.001. Online ahead of print.

Aladesuru O, Amankwah K, Elterman D, Zorn KC, Bhojani N, Teet A et al. Pilot Study of “Less is More” Rezum for Treatment of BPH. Urology. 2022:S0090–4295(22)00094-2. https://doi.org/10.1016/j.urology.2022.01.039. Online ahead of print.

Sokolakis I, Pyrgidis N, Russo GI, Sountoulides P, Hatzichristodoulou G. Preserving Ejaculation: A Guide Through the Landscape of Interventional and Surgical Options for Benign Prostatic Obstruction. Eur Urol Focus. 2022:S2405–4569(22)00062-1. https://doi.org/10.1016/j.euf.2022.03.008. Online ahead of print.